CCAM
ABT icon

Cascades Capital Asset Management’s Abbott ABT Stock Holding History

Cascades Capital Asset Management’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$188K Sell
1,829
-37
-2% -$4.18K 0.08% 132
2025
Q4 		$234K Sell
1,866
-21
-1% -$2.67K 0.1% 119
2025
Q3 		$253K Sell
1,887
-19
-1% -$2.49K 0.11% 112
2025
Q2 		$259K Buy
1,906
+226
+13% +$29.8K 0.13% 91
2025
Q1 		$223K Buy
+1,680
New +$214K 0.12% 104

Other funds holding ABT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cascades Capital Asset Management's ABT Position: Q1 2026 in Review

Cascades Capital Asset Management reduced its Abbott (ABT) stake by 2% in Q1 2026, selling an estimated $4.18K and leaving 1,829 shares worth $188K. The position accounts for 0.08% of the portfolio, ranked #132.

Cascades Capital Asset Management first reported a position in ABT in Q1 2025 and has held it in 5 quarters since. The position peaked at $259K in Q2 2025. 3,090 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Cascades Capital Asset Management held 1,829 shares of Abbott worth $188K as of Q1 2026.
  • Cascades Capital Asset Management sold 37 Abbott shares in Q1 2026, an estimated $4.18K.
  • Abbott made up 0.08% of Cascades Capital Asset Management's portfolio in Q1 2026, its #132 holding.
  • Cascades Capital Asset Management first reported a position in Abbott in Q1 2025 and has held it in 5 quarters since.
  • Cascades Capital Asset Management's Abbott position peaked at $259K in Q2 2025.
  • 3,090 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Cascades Capital Asset Management's 13F filing for Q1 2026, filed 15 May 2026.